0001104659-23-118287.txt : 20231114 0001104659-23-118287.hdr.sgml : 20231114 20231114184854 ACCESSION NUMBER: 0001104659-23-118287 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BeiGene, Ltd. CENTRAL INDEX KEY: 0001651308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981209416 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37686 FILM NUMBER: 231408503 BUSINESS ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVENUE, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 BUSINESS PHONE: 13459494123 MAIL ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVENUE, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Baker Brothers Life Sciences LP CENTRAL INDEX KEY: 0001363364 IRS NUMBER: 861125324 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: 860 WASHINGTON STREET STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 212-339-5600 MAIL ADDRESS: STREET 1: 860 WASHINGTON STREET STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 144 1 primary_doc.xml 144 0001363364 XXXXXXXX LIVE 0001651308 BeiGene, Ltd. 001-37686 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108 345-949-4123 Baker Brothers Life Sciences, L.P. Affiliate American Depositary Shares J.P. Morgan

Securities LLC 383 Madison Avenue NY 10179

1008660 200572041.00 67064123 11/14/2023 NASDAQ American Depositary Shares 07/15/2020 Purchase of ordinary shares from issuer in registered direct transaction later converted to American Depositary Shares Issuer N 13589904 07/15/2020 Cash Y Baker Brothers Life Sciences, L.P. is affiliated with 667, L.P. Baker Bros. Advisors LP is the investment adviser to 667, L.P. and Baker Brothers Life Sciences, L.P. 667, L.P. is filing separately for the sale of 91,340 American Depositary Shares ("ADS") of BeiGene, Ltd (the "Issuer"), which along with the reported sales in this form by Baker Brothers Life Sciences, L.P. totals 1,100,000 ADS. Each ADS represents 13 Ordinary Shares of the Issuer. The outstanding shares number noted above represents outstanding ADS. 11/14/2023 By: BAKER BROS. ADVISORS LP, mgmt company and IA to Baker Brothers Life Sciences, L.P., /s/ Scott L. Lessing, President